Insider · CIK 0001816952
Daphne Karydas
Files at CMPS (COMPASS Pathways plc), MLYS (Mineralys Therapeutics, Inc.). First filing Sep 17, 2026, latest Sep 17, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
MLYS: Mineralys Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 14Weak | Mineralys Therapeutics, Inc. | $86k 3,000 shares | -33% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | MLYS Mineralys Therapeutics, Inc. | MOption exercise Common Stock10b5-1 | +3,000 | $12.02 | $36k | 9,200 | 25 d ago |
| Sep 15, 2026 | MLYS Mineralys Therapeutics, Inc. | SOpen-market sale Common Stock10b5-1 | -3,000 | $28.58 | $86k | 6,200 | 25 d ago |
| Sep 15, 2026 | MLYS Mineralys Therapeutics, Inc. | MOption exercise Stock Optionderivative10b5-1 | -3,000 | $0.00 | $0 | 35,000 | 25 d ago |
| Jun 12, 2025 | CMPS COMPASS Pathways plc | AGrant or award Share Option (Right to Buy)derivative | +26,000 | $0.00 | $0 | 26,000 | Jun 13, 2025 |
| Feb 13, 2025 | MLYS Mineralys Therapeutics, Inc. | AGrant or award Stock Optionderivative | +32,900 | $0.00 | $0 | 32,900 | Feb 24, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.